Niosomes in cancer treatment: A focus on curcumin encapsulation.
Application
Cancer
Curcumin
Formulation
Niosome
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
15
12
2022
revised:
24
07
2023
accepted:
25
07
2023
medline:
18
8
2023
pubmed:
18
8
2023
entrez:
18
8
2023
Statut:
epublish
Résumé
Curcumin is widely used as a therapeutic drug for cancer treatment. However, its limited absorption and rapid excretion are the major therapeutic limitations to its clinical use. Using niosomes as a curcumin delivery system is a cheap, easy, and less toxic strategy for enhancing the absorption of curcumin by cells and delaying its excretion. Thus, there is a vital need to explore curcumin niosomes to configure the curcumin to suitably serve and aid current pharmacokinetics in treatments for cancer. To date, no comprehensive review has focused on the cytotoxic effects of curcumin niosomes on malignant cells. Thus, this review provides a critical analysis of the curcumin niosomes in cancer treatment, formulations of curcumin niosomes, characterizations of curcumin niosomes, and factors influencing their performance. The findings from this review article can strongly accelerate the understanding of curcumin niosomes and pave a brighter direction towards advances in the pharmaceutical, biotechnology, and medical industries.
Identifiants
pubmed: 37593605
doi: 10.1016/j.heliyon.2023.e18710
pii: S2405-8440(23)05918-2
pmc: PMC10428065
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e18710Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Colloids Surf B Biointerfaces. 2013 Feb 1;102:803-7
pubmed: 23107959
Drug Dev Ind Pharm. 2002 Nov;28(10):1181-93
pubmed: 12476864
J Control Release. 2014 Jan 28;174:27-36
pubmed: 24231407
Eur J Pharm Sci. 2022 Jan 1;168:106052
pubmed: 34740786
Adv Pharmacol Sci. 2018 Dec 11;2018:6847971
pubmed: 30651728
Asian J Pharm Sci. 2019 Mar;14(2):117-129
pubmed: 32104444
Colloids Surf B Biointerfaces. 2011 Oct 1;87(1):28-35
pubmed: 21621983
Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:171-185
pubmed: 31146988
BMC Res Notes. 2015 Feb 20;8:47
pubmed: 25884200
J Phys Chem B. 2013 Jun 13;117(23):6957-68
pubmed: 23682632
Iran J Pathol. 2022 Spring;17(2):183-190
pubmed: 35463725
J Control Release. 2009 Jan 19;133(2):96-102
pubmed: 18840485
J Microencapsul. 2019 Mar;36(2):169-179
pubmed: 31104531
Mol Cell. 2005 Sep 2;19(5):581-93
pubmed: 16137616
AAPS PharmSciTech. 2017 Jul;18(5):1554-1563
pubmed: 27604883
J Agric Food Chem. 2017 Mar 1;65(8):1525-1532
pubmed: 27935709
Crit Rev Clin Lab Sci. 2002 Nov;39(6):527-79
pubmed: 12484499
Front Cell Dev Biol. 2021 Mar 04;9:645402
pubmed: 33748140
Biology (Basel). 2021 Feb 26;10(3):
pubmed: 33652630
Eur J Epidemiol. 2014 Jan;29(1):35-48
pubmed: 24271556
Int J Nanomedicine. 2014 Dec 30;10:257-70
pubmed: 25565818
Sci Rep. 2017 Sep 5;7(1):10542
pubmed: 28874846
Food Chem. 2020 Oct 1;326:126973
pubmed: 32413757
Cancer Chemother Pharmacol. 2015 Feb;75(2):221-34
pubmed: 25212538
J Pharm Biomed Anal. 1997 Aug;15(12):1867-76
pubmed: 9278892
Phytother Res. 2020 Aug;34(8):1992-2005
pubmed: 32141677
Cancer Drug Resist. 2021 Jun 19;4(2):264-297
pubmed: 35582024
ACS Appl Mater Interfaces. 2017 Jun 7;9(22):18462-18473
pubmed: 28497681
Eur J Pharm Sci. 2011 Sep 18;44(1-2):93-102
pubmed: 21726640
Biol Pharm Bull. 2011;34(7):945-53
pubmed: 21719996
Mater Sci Eng C Mater Biol Appl. 2015 Nov 1;56:393-400
pubmed: 26249606
Molecules. 2015 Feb 12;20(2):3020-6
pubmed: 25685909
PLoS One. 2014 Dec 11;9(12):e114588
pubmed: 25501971
Mol Pharm. 2018 Dec 3;15(12):5653-5664
pubmed: 30375877
Pathol Res Pract. 2019 Oct;215(10):152556
pubmed: 31358480
Mater Sci Eng C Mater Biol Appl. 2020 Aug;113:110975
pubmed: 32487392
Langmuir. 2016 Sep 6;32(35):8926-33
pubmed: 27504856
Pharmacol Res. 2014 Jan;79:34-74
pubmed: 24269963
EXCLI J. 2015 Jan 06;14:21-32
pubmed: 26417350
AAPS J. 2009 Sep;11(3):495-510
pubmed: 19590964
J Biol Chem. 2008 Jun 6;283(23):15647-55
pubmed: 18375392
Gynecol Oncol. 2008 Mar;108(3):619-26
pubmed: 18222534
Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110597
pubmed: 32228991
Eur J Med Chem. 2015 Aug 28;101:584-94
pubmed: 26197162
J Adv Pharm Technol Res. 2010 Oct;1(4):374-80
pubmed: 22247876
Nanobiomedicine (Rij). 2018 Oct 11;5:1849543518805355
pubmed: 30344765
Transl Androl Urol. 2013 Jun;2(2):114-6
pubmed: 26816733
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Eur J Pharm Sci. 2018 Oct 15;123:228-240
pubmed: 30031862
Radiology. 2004 Apr;231(1):135-42
pubmed: 15068944
Int J Biol Macromol. 2021 Jul 1;182:1981-1993
pubmed: 34058209
J Liposome Res. 2020 Jun;30(2):126-135
pubmed: 30935273
J Hepatol. 2012 Mar;56(3):686-95
pubmed: 21971559
Chem Phys Lipids. 2021 Jan;234:105019
pubmed: 33232724
Inorg Chem. 2014 May 19;53(10):4922-33
pubmed: 24766626
J Nanobiotechnology. 2018 Mar 23;16(1):28
pubmed: 29571289
Tumour Biol. 2014 Oct;35(10):9801-6
pubmed: 24981249
IUBMB Life. 2009 Jul;61(7):697-706
pubmed: 19514019
Mol Cancer. 2011 Feb 07;10:12
pubmed: 21299897
Int J Nanomedicine. 2014 Jun 05;9:2767-78
pubmed: 24940057
Angiogenesis. 2004;7(4):335-45
pubmed: 15886877
Eur J Pharm Sci. 2019 Mar 15;130:234-246
pubmed: 30711688
CA Cancer J Clin. 2019 Nov;69(6):452-467
pubmed: 31390062
Nano Lett. 2013;13(12):6002-8
pubmed: 24237230
Artif Cells Nanomed Biotechnol. 2018 May;46(3):524-535
pubmed: 28509572
Int J Nanomedicine. 2019 May 07;14:3311-3330
pubmed: 31190795
Eur J Cancer. 2010 May;46(7):1271-7
pubmed: 20303742
Gastroenterology. 2011 May;140(5):1410-26
pubmed: 21406195
Hum Pathol. 2008 Apr;39(4):498-505
pubmed: 18342661
Drug Dev Ind Pharm. 2018 Aug;44(8):1371-1376
pubmed: 29532687
Annu Rev Pathol. 2011;6:49-69
pubmed: 20887192
Int J Pharm. 2020 Feb 25;576:119024
pubmed: 31926974
Drug Des Devel Ther. 2019 Oct 30;13:3753-3772
pubmed: 31802849
Oncotarget. 2016 May 31;7(22):32144-55
pubmed: 27014973
Int J Pharm. 2013 Nov 18;456(2):446-58
pubmed: 23998955
Carbohydr Polym. 2013 Apr 15;94(1):634-41
pubmed: 23544584
Int J Pharm. 2021 Jul 15;604:120534
pubmed: 33781887
J Agric Food Chem. 2015 Sep 9;63(35):7606-14
pubmed: 25817068
Carbohydr Polym. 2021 Apr 1;257:117572
pubmed: 33541631
EBioMedicine. 2020 Jun;56:102821
pubmed: 32505922
Chem Sci. 2017 Dec 18;9(4):790-810
pubmed: 29675145
Cancers (Basel). 2020 Oct 16;12(10):
pubmed: 33081407
RSC Adv. 2018 Sep 21;8(57):32621-32636
pubmed: 35547672
Soft Matter. 2020 Feb 19;16(7):1779-1791
pubmed: 31970372
Asian Pac J Cancer Prev. ;18(2):365-368
pubmed: 28345332
Adv Colloid Interface Sci. 2014 Mar;205:187-206
pubmed: 24369107
Molecules. 2021 Jun 05;26(11):
pubmed: 34198955
Oncotarget. 2015 Aug 14;6(23):19469-82
pubmed: 26254223
Int J Pharm. 2020 Jun 15;583:119340
pubmed: 32305363
Int J Pharm. 2015 Sep 30;493(1-2):285-94
pubmed: 26200748
J Clin Neurosci. 2016 Dec;34:1-5
pubmed: 27578526
Int J Pharm. 2019 Aug 15;567:118431
pubmed: 31207279
Bioorg Chem. 2021 Oct;115:105116
pubmed: 34333420
Mater Sci Eng C Mater Biol Appl. 2019 Jan 1;94:291-302
pubmed: 30423711
Int J Biol Sci. 2013;9(2):142-8
pubmed: 23411680
J Inorg Biochem. 2017 Aug;173:113-119
pubmed: 28511061
J Clin Pharmacol. 1998 Nov;38(11):981-93
pubmed: 9824778
Pharmaceutics. 2018 Mar 22;10(2):
pubmed: 29565809
Adv Drug Deliv Rev. 2021 Dec;179:113905
pubmed: 34331988
Polymers (Basel). 2021 Mar 04;13(5):
pubmed: 33806659
Drug Deliv Transl Res. 2018 Jun;8(3):633-644
pubmed: 29488171
Int J Mol Sci. 2021 Jul 01;22(13):
pubmed: 34281181
Cancer Res. 1988 Nov 1;48(21):5941-6
pubmed: 3139287
J Pharm Sci. 2017 Jan;106(1):111-122
pubmed: 27544432
Expert Rev Mol Med. 2011 Nov 04;13:e34
pubmed: 22051121
J Altern Complement Med. 2003 Feb;9(1):161-8
pubmed: 12676044
Pharmaceuticals (Basel). 2022 Mar 09;15(3):
pubmed: 35337128
Am J Respir Cell Mol Biol. 1997 Jul;17(1):3-9
pubmed: 9224203